Form 4: Definitive Healthcare CEO Acquires Shares

Kevin Coop, CEO of Definitive Healthcare Corp., acquired 66,050 shares of Class A Common Stock through a tax withholding transaction.

Summary

• Kevin Coop, Chief Executive Officer and Director of Definitive Healthcare Corp., acquired 66,050 shares of Class A Common Stock.
• The acquisition occurred on June 1, 2026, with a transaction price of $0.99 per share.
• These shares were acquired through a withholding mechanism by the issuer to satisfy the reporting person's tax obligations related to the vesting and settlement of previously reported Restricted Stock Units (RSUs).
• Following this transaction, Coop beneficially owns 5,012,822 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves a significant number of shares, the transaction is a routine tax withholding related to RSU vesting, not a new investment or sale by the executive.

Positives

• The CEO's acquisition of shares, even if through a tax withholding mechanism, indicates continued direct ownership and potential confidence in the company.
• The transaction involves the settlement of previously granted RSUs, suggesting a component of executive compensation tied to company performance or vesting schedules.

Negatives

• The transaction is a tax withholding, meaning shares were used to cover tax liabilities rather than an outright purchase with new capital.
• The reported price of $0.99 per share is significantly lower than typical market prices for publicly traded companies, suggesting these are likely related to the RSU settlement value at a specific point in time or a nominal value for tax purposes.

Risks

• The filing does not explicitly detail any new risks. However, the underlying RSUs could be subject to forfeiture if vesting conditions are not met.
• The low transaction price of $0.99 per share might reflect a historical valuation or a specific condition of the RSU settlement, which could be a point of concern if it deviates significantly from current market value.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future financial performance.

Management Comments

• The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of previously reported RSUs.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by the CEO of Definitive Healthcare Corp., are common in the healthcare technology sector. These filings provide transparency into executive compensation and potential insider sentiment, though this specific transaction is primarily a tax-related event rather than a discretionary purchase.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact share price or company value, as it's a tax-related event. However, it confirms the CEO's continued direct beneficial ownership.
• Employees: The RSU vesting and settlement process is a standard component of executive compensation, reflecting the company's incentive structures.
• Management: Confirms the CEO's ongoing role and compensation tied to company equity.

Next Steps

• Continued monitoring of insider transactions for any discretionary buying or selling activity by management.
• Review of future SEC filings for updates on Definitive Healthcare Corp.'s financial performance and strategic initiatives.

Key Dates

Keywords

Definitive Healthcare Corp., Kevin Coop, Form 4, SEC Filing, Insider Transaction, Class A Common Stock, RSU Vesting, Tax Withholding, Beneficial Ownership